Potential use of psilocybin drugs in the treatment of depression
Expert Opinion on Emerging Drugs October 2, 2023 Katarzyna Śladowska, Paweł Kawalec, Tomasz Brzostek et al. 4 citations
Psilocybin shows promise in early clinical trials for treating major depressive disorder and treatment-resistant depression, with effects appearing relatively quickly after administration. However, large phase III trials are still needed to confirm its efficacy and safety before it can be approved and accepted by physicians and patients.